Multiphoton microscopy is a valuable tool for neuroscience research, allowing scientists to observe functional brain activity ...

Researchers at Massachusetts General Hospital developed a novel cannula delivery system for effective compound administration ...

Life Molecular Imaging (LMI) and PharmaLogic Holdings Corp. (PharmaLogic), a world-class contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, announce the ...

Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the prostate cancer imaging agent ...

Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research April 24th, 2025 Martigny, Switzerland. Dijon, France – Debiopharm Research & ...

Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual meeting: Berlin, Germany Wednesday, April 23, 2025, 10:00 Hrs ...

MELBOURNE, Australia, April 15, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET [1] imaging agent ...

Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery. The appointment reflects the company’s ...

Data center equipment maker Vertiv (NYSE: VRT), healthcare technology specialist GE HealthCare Technologies (NASDAQ:GEHC), and electrical protection and connection products company nVent Electric ...

Veru has evolved its drug development strategy for sabizabulin and is exploring the possibility of the clinical development ...

The majority of its products that are ... GE Healthcare is a leader in imaging equipment and, at the same time, makes pharmaceutical diagnostics (imaging agents used to diagnose and even guide ...